This work was supported by the National Institute for Health Research (NIHR) CLAHRC for Cambridgeshire and Peterborough, CIBERSAM, Spain and the Oxford Biomedical Research Centre. MSZ holds an Eastern Region Neurosciences Training Fellowship. SRI held an NIHR clinical training fellowship. We also wish to acknowledge Professor F. Anne Stephenson, at the School of Pharmacy, University of London for her help in developing the NMDAR assay. We would like to thank Prof D Beeson and Ms S Maxwell for their assistance with the cloning and expression of NMDAR subunits, Dr F Winton as clinical referrer and Dr J Stochl for help with the Cameo demographic data.
Conflict of interest
MZ and PW report no disclosures. SRI, PBJ and BLe receive support from the NIHR. AJC reports receiving consulting fees, lecture fees, and grant support from Genzyme. PMcK is supported by CIBERSAM, Spain. AV receives royalties from Athena Diagnostics, and the department of Clinical Neurology in Oxford receives royalties and payments for antibody assays.
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.